Skip to main content
Daanish Hoda, MD, Oncology, Salt Lake City, UT, LDS Hospital

DaanishHodaMD

Oncology • Salt Lake City, UT

Hematologic Oncology

Oncology Program Associate Medical Director of Hematology Intermountain Health

Join to view full profile

Dr. Hoda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hoda's full profile

Already have an account?

Summary

  • Dr. Hoda is an Oncology Program Associate Medical Director of Hematology and works at the Intermountain Health's Hematologic Malignancy Program performing high risk leukemia treatments and stem cell transplants, and oversees the Classical Hematology Virtual Clinic.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2005
  • University of Miami Leonard M. Miller School of Medicine
    University of Miami Leonard M. Miller School of MedicineClass of 2002

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2009 - 2026
  • NV State Medical License
    NV State Medical License 2020 - 2025
  • CO State Medical License
    CO State Medical License 2020 - 2025
  • MT State Medical License
    MT State Medical License 2019 - 2025
  • ID State Medical License
    ID State Medical License 2020 - 2024
  • FL State Medical License
    FL State Medical License 2006 - 2011
  • MN State Medical License
    MN State Medical License 2003 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
    Daanish Hoda, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • ASH Recognizes Choosing Wisely, Guideline Implementation Champions
    ASH Recognizes Choosing Wisely, Guideline Implementation ChampionsDecember 29th, 2022
  • 14 More Utahns Die of COVID-19. And, Yes, We’re Still in a Surge
    14 More Utahns Die of COVID-19. And, Yes, We’re Still in a SurgeJuly 7th, 2022
  • Approval of Blood Plasma Treatment Has Implications for Utah’s COVID-19 Patients and Researchers
    Approval of Blood Plasma Treatment Has Implications for Utah’s COVID-19 Patients and ResearchersAugust 24th, 2020
  • Join now to see all

Hospital Affiliations

Dr. Daanish Hoda, Dr. Daanish Hoda, MD, Dr. D Hoda